Lee Ainslie Tandem Diabetes Care Inc Transaction History

Maverick Capital LTD

  • $4.82 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$35.86 - $46.5 $559,953 - $726,097
15,615 New
15,615 $634,000
Q1 2022

May 16, 2022
SELL
$101.89 - $150.09 $73,462 - $108,214
-721 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$118.18 - $153.21 $779,869 - $1.01 Million
-6,599 Reduced 90.15%
721 $109,000
Q3 2021

Nov 15, 2021
BUY
$93.51 - $129.4 $684,493 - $947,208
7,320 New
7,320 $874,000

Others Institutions Holding TNDM

# of Institutions
360
Shares Held
72.5M
Call Options Held
3.36M
Put Options Held
229K
View Full List

About TANDEM DIABETES CARE INC

TNDM Quotes by TradingView
  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $1.97B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email